Literature DB >> 7172406

Absorption and distribution of vaginally administered misonidazole.

D Ash, R Bugden, R Calvert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7172406     DOI： 10.1007/bf00265391

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  5 in total

1.  Radiosensitization of solid tumors by nitroimidazoles.

Authors:  J Denekamp; J F Fowler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1978 Jan-Feb       Impact factor: 7.038

2.  Biliary and faecal excretion of misonidazole in man.

Authors:  D V Ash; M R Smith
Journal:  Br J Radiol       Date:  1979-10       Impact factor: 3.039

3.  Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography.

Authors:  P Workman; C J Little; T R Marten; A D Dale; R J Ruane; I R Flockhart; N M Bleehen
Journal:  J Chromatogr       Date:  1978-05-01

4.  Penetration of misonidazole after intravesical administration in cases of carcinoma of the bilharzial bladder.

Authors:  H K Awwad; M M el-Merzabani; M V Burgers
Journal:  Br J Cancer Suppl       Date:  1978-06

5.  Distribution of misonidazole in human tumours and normal tissues.

Authors:  D V Ash; M R Smith; R D Bugden
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.